Latest On Antares Pharma, Inc (ATRS):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-04-14 19:36 EST | News | Antares Pharma downgraded by Raymond James, 4 others after Halozyme ~$1B acquisition offer | N/A |  |
| 2022-04-14 05:03 EST | News | Antares Pharma stock soars 49% on ~$1B acquisition deal by Halozyme | N/A | |
| 2022-04-14 05:02 EST | News | Hot Stocks: Travel stocks rally; SRRA, ATRS jump on merger deals; NSTG plunges; BCYC extends low | N/A | |
| 2022-04-13 14:21 EST | News | Antares Pharma stock soars 47% on ~$1B acquisition deal by Halozyme | N/A | |
| 2022-03-29 22:12 EST | News | Antares wins full FDA approval for testosterone replacement therapy | N/A | |
| 2022-03-09 03:27 EST | News | Antares Pharma (ATRS) Investor Presentation - Slideshow | N/A | |
| 2022-03-04 19:04 EST | News | Antares Pharma, Inc.'s (ATRS) CEO Robert Apple on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-04 01:31 EST | News | Antares Pharma, Inc. 2021 Q4 - Results - Earnings Call Presentation | N/A | |
| 2022-03-04 01:31 EST | News | Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q4 2021 Results - Earnings Call Transcript | N/A | |
| 2022-03-03 08:00 EST | News | Antares Pharma Non-GAAP EPS of $0.02 beats by $0.01, revenue of $48.73M beats by $1.54M | N/A | |
| 2022-03-02 13:42 EST | News | Antares Pharma Q4 2021 Earnings Preview | N/A | |
| 2022-02-04 00:47 EST | News | Antares resubmitted NDA for testosterone replacement therapy Tlando accepted by FDA | N/A | |
| 2022-01-24 17:14 EST | News | A Look At Recent Moves By Antares Pharma | N/A | |
| 2022-01-18 17:40 EST | News | Antares Pharma's ATRS-1902 gets US FDA fast track status for adrenal crisis rescue | N/A | |
| 2022-01-12 01:14 EST | News | Antares Pharma reports positive results from Phase I ATRS-1902 study for adrenal crisis | N/A | |
| 2021-11-05 21:32 EST | News | Antares Pharma, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-11-05 01:28 EST | News | Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-11-04 04:18 EST | News | Antares Pharma Q3 2021 Earnings Preview | N/A | |
| 2021-10-01 08:19 EST | News | Antares Pharma launches Phase I study of ATRS-1902 for adrenal crisis rescue | N/A | |
| 2021-08-05 22:22 EST | News | Antares Pharma, Inc. 2021 Q2 - Results - Earnings Call Presentation | N/A | |
| 2021-08-05 22:22 EST | News | Antares Pharma's (ATRS) CEO Robert Apple on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-07-22 19:19 EST | News | FDA accepts Antares' ATRS-1902 IND for adrenal crisis rescue | N/A | |
| 2021-07-20 20:01 EST | News | Antares Pharma: Momentum Set To Continue In Q2 | N/A | |
| 2021-07-20 19:51 EST | News | Antares Pharma submits IND application for ATRS-1902 for adrenal crisis rescue | N/A | |
| 2021-05-07 04:01 EST | News | Antares Pharma posts Q1 earnings beat, maintains FY revenue forecast | N/A | |
| 2021-05-07 03:59 EST | News | Antares Pharma, Inc. 2021 Q1 - Results - Earnings Call Presentation | N/A | |
| 2021-05-07 03:59 EST | News | Antares Pharma, Inc. (ATRS) CEO Robert Apple on Q1 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-27 12:32 EST | News | Antares Pharma - Why It's A $4 Stock (And Might Remain So) | N/A | |
| 2021-04-26 16:29 EST | News | Antares Pharma appoints Richardson as executive Vice President, CMO | N/A | |
| 2021-03-04 07:09 EST | Financials | Company financials have been released. | Neutral | |
| 2021-03-03 22:24 EST | News | Antares Pharma, Inc. 2020 Q4 - Results - Earnings Call Presentation | N/A | |
| 2021-03-03 07:11 EST | Earnings Estimate | An EPS average of $0.28 is estimated for the 2022 year. | Buy | |
| 2021-03-03 07:11 EST | Earnings Estimate | An EPS average of $0.03 is estimated for the quarter ending on June 30, 2021. | N/A | |
| 2021-03-03 03:03 EST | News | Antares Pharma's (ATRS) CEO Bob Apple on Q4 2020 Results - Earnings Call Transcript | N/A | |
| 2021-03-02 08:21 EST | News | Antares Pharma EPS beats by $0.26, beats on revenue; reaffirms guidance | N/A | |
| 2021-02-10 07:10 EST | Analyst Rating | The Analyst Target Price has increased from $6.25 to $6.42. | Buy | |
| 2021-01-26 04:52 EST | News | Antares: Ready To Make Another Attempt At Breaking Out Above $5 | N/A | |
| 2021-01-11 14:40 EST | News | Antares Pharma trades higher on revenue guidance for FY 2021 | N/A | |
| 2021-01-02 15:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-12-13 03:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-15 11:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-10 03:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-06 07:09 EST | Earnings Estimate | An EPS average of $0.04 is estimated for the quarter ending on March 31, 2021. | Buy | |
| 2020-11-06 02:51 EST | News | Antares Pharma EPS in-line, beats on revenue | N/A | |
| 2020-11-06 02:51 EST | News | Antares Pharma, Inc. 2020 Q3 - Results - Earnings Call Presentation | N/A | |
| 2020-11-06 02:50 EST | News | Antares Pharma, Inc. (ATRS) CEO Bob Apple on Q3 2020 Results - Earnings Call Transcript | N/A | |
| 2020-11-01 17:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-09 22:37 EST | News | Antares Is Finally Having A Long Overdue Upward Move | N/A | |
| 2020-10-02 13:59 EST | News | Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. | N/A | |
| 2020-09-26 04:21 EST | Financials | Company financials have been released. | Neutral | |
About Antares Pharma, Inc (ATRS):
Antares Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of pharmaceutical products and technologies that address unmet needs in targeted therapeutic areas. It develops, manufactures, and commercialize novel therapeutic products using its drug delivery systems. The company's injection products include XYOSTED for subcutaneous administration of testosterone replacement therapy in adult males; OTREXUP OTREXUP a subcutaneous methotrexate injection indicated for adults with severe active rheumatoid arthritis, children with active polyarticular juvenile idiopathic arthritis, and adults with severe recalcitrant psoriasis; and NOCDURNA sublingual tablets indicated for the treatment of nocturia due to nocturnal polyuria in adults who awaken at least two times per night to urinate. Its injection products also comprise generic Epinephrine Injection USP products indicated for emergency treatment of severe allergic reactions, including anaphylaxis in adults and certain pediatric patients; Sumatriptan Injection USP indicated for the acute treatment of migraine headaches and cluster headache in adults; and Makena subcutaneous auto injector drug-device combination product indicated to reduce the risk of preterm birth in women, as well as Teriparatide injection used for the treatment of osteoporosis in postmenopausal women and men at increased risk of fracture, and for glucocorticoid induced osteoporosis in men and women. In addition, the company develops disposable pen injectors for diabetes and osteoporosis; QuickShot auto injectors; and drug/device product for urologic oncology and endocrinology. The company have strategic alliances and partnership arrangements pharmaceutical companies, including Pfizer, Idorsia, Teva, and AMAG. Antares Pharma, Inc. was founded in 1978 and is headquartered in Ewing, New Jersey.
General
- Name Antares Pharma, Inc
- Symbol ATRS
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 185
- Last Split Factor1:5
- Last Split Date1999-01-29
- Fiscal Year EndDecember
- IPO Date1996-10-02
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.antarespharma.com
View More
Valuation
- Trailing PE 12.91
- Forward PE 15.53
- Price/Sales (Trailing 12 Mt.) 4.97
- Price/Book (Most Recent Quarter) 6.17
- Enterprise Value Revenue 4.87
- Enterprise Value EBITDA 44.61
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $0.15
- Next Year EPS Estimate $0.27
- Next Quarter EPS Estimate $0.03
- Profit Margin 38%
- Operating Margin 9%
- Return on Assets 5%
- Return on Equity 65%
- Revenue 149.6 million
- Earnings Per Share $0.33
- Revenue Per Share $0.9
- Gross Profit 86.5 million
- Quarterly Earnings Growth 16.6%
View More
Highlights
- Market Capitalization 716.37 million
- EBITDA 16.25 million
- PEG Ratio -0.26
- Analyst Target Price $6.42
- Book Value Per Share $0.71
View More
Share Statistics
- Shares Outstanding 168.16 million
- Shares Float 155.95 million
- % Held by Insiders 749%
- % Held by Institutions 43.95%
- Shares Short 4.1 million
- Shares Short Prior Month 3.92 million
- Short Ratio 2.9
- Short % of Float 2%
- Short % of Shares Outstanding 2%
View More
Technicals
- Beta 1.41
- 52 Week High $5.07
- 52 Week Low $1.6
- 50 Day Moving Average 4.45
- 200 Day Moving Average 3.58
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
View More
Antares Pharma, Inc (ATRS) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Antares Pharma, Inc (ATRS) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-03-02 | $44.11 million | $0.03 | $0.04 | -14.29% |
| 2020-09-30 | 2020-11-05 | $40 million | $0.03 | $0.02 | 28.76% |
| 2020-06-30 | 2020-08-06 | $N/A | $0.01 | $-0.00 | 403.03% |
| 2020-03-31 | 2020-05-05 | $33.08 million | -$0.01 | -$0.01 | 0% |
| 2019-12-31 | 2020-03-03 | $37.84 million | $0.03 | $0.00 | 809.09% |
| 2019-09-30 | 2019-11-05 | $34.31 million | $0.01 | -$0.02 | 150% |
| 2019-06-30 | 2019-08-06 | $28.43 million | -$0.01 | -$0.04 | 73.68% |
| 2019-03-31 | 2019-05-02 | $23.29 million | -$0.03 | -$0.04 | 25% |
| 2018-12-31 | 2019-02-28 | $18.82 million | -$0.04 | -$0.03 | -38.33% |
| 2018-09-30 | 2018-11-06 | $17.87 million | -$0.01 | -$0.02 | 50% |
| 2018-06-30 | 2018-08-07 | $14.16 million | -$0.03 | -$0.02 | -36.36% |
| 2018-03-31 | 2018-05-08 | $12.7 million | -$0.04 | -$0.03 | -42.86% |
| 2017-12-31 | 2018-03-13 | $14.04 million | -$0.02 | -$0.03 | 23.08% |
| 2017-09-30 | 2017-11-07 | $15.05 million | -$0.03 | -$0.03 | -20% |
| 2017-06-30 | 2017-08-08 | $13.42 million | -$0.02 | -$0.03 | 33.33% |
| 2017-03-31 | 2017-05-09 | $12.01 million | -$0.03 | -$0.03 | 9.91% |
| 2016-12-31 | 2017-03-14 | $14.2 million | -$0.03 | -$0.04 | 25% |
| 2016-09-30 | 2016-11-09 | $13.48 million | -$0.04 | -$0.03 | -20.12% |
| 2016-06-30 | 2016-08-09 | $12.23 million | -$0.04 | -$0.04 | 7.62% |
| 2016-03-31 | 2016-05-09 | $12.32 million | -$0.05 | -$0.03 | -50.15% |
| 2015-12-31 | 2016-03-08 | $11.8 million | -$0.04 | -$0.03 | -33.33% |
| 2015-09-30 | 2015-11-05 | $11.09 million | -$0.04 | -$0.04 | 0% |
| 2015-06-30 | 2015-08-10 | $14.42 million | -$0.01 | -$0.03 | 66.67% |
| 2015-03-31 | 2015-05-11 | $8.35 million | -$0.05 | -$0.04 | -25% |
| 2014-12-31 | 2015-03-12 | $8.4 million | -$0.08 | -$0.05 | -60% |
| 2014-09-30 | 2014-11-06 | $6.57 million | -$0.05 | -$0.06 | 16.67% |
| 2014-06-30 | 2014-08-07 | $6.33 million | -$0.07 | -$0.07 | 0% |
| 2014-03-31 | 2014-05-09 | $5.2 million | -$0.07 | -$0.05 | -40% |
| 2013-12-31 | 2014-03-13 | $4.75 million | -$0.04 | -$0.05 | 20% |
| 2013-09-30 | 2013-11-06 | $5.51 million | -$0.05 | -$0.04 | -25% |
| 2013-06-30 | 2013-08-07 | $5.84 million | -$0.04 | -$0.03 | -33.33% |
| 2013-03-31 | 2013-05-08 | $4.53 million | -$0.03 | -$0.03 | 0% |
| 2012-12-31 | 2013-03-13 | $5.5 million | -$0.04 | -$0.03 | -33.33% |
| 2012-09-30 | 2012-11-07 | $5.69 million | -$0.03 | -$0.02 | -50% |
| 2012-06-30 | 2012-08-08 | $4.52 million | -$0.03 | -$0.02 | -50% |
| 2012-03-31 | 2012-05-08 | $6.87 million | $-0.00 | -$0.01 | 93% |
| 2011-12-31 | 2012-03-12 | $5.43 million | $-0.00 | ||
| 2011-09-30 | 2011-11-08 | $3.92 million | -$0.01 | -$0.01 | 0% |
| 2011-06-30 | 2011-08-08 | $3.54 million | -$0.02 | -$0.01 | -100% |
| 2011-03-31 | 2011-05-09 | $3.57 million | -$0.02 | -$0.02 | 0% |
| 2010-12-31 | 2011-03-14 | $3.28 million | -$0.02 | -$0.02 | 0% |
| 2010-09-30 | 2010-11-10 | $3.12 million | -$0.02 | -$0.02 | 0% |
| 2010-06-30 | 2010-08-12 | $3.05 million | -$0.02 | -$0.02 | 0% |
| 2010-03-31 | 2010-05-13 | $3.36 million | -$0.02 | -$0.04 | 50% |
| 2009-12-31 | 2010-03-23 | $2.58 million | -$0.03 | -$0.02 | -50% |
| 2009-09-30 | 2009-11-09 | $1.65 million | -$0.04 | -$0.04 | 0% |
| 2009-06-30 | 2009-08-13 | $1.71 million | -$0.03 | -$0.05 | 40% |
| 2009-03-31 | 2009-05-13 | $2.37 million | -$0.04 | -$0.05 | 20% |
| 2008-12-31 | 2009-03-25 | $1.77 million | -$0.04 | -$0.05 | 20% |
| 2008-09-30 | 2008-11-13 | $1.39 million | -$0.05 | -$0.05 | 0% |
| 2008-06-30 | 2008-08-14 | $1.39 million | -$0.05 | -$0.05 | 0% |
| 2008-03-31 | 2008-05-15 | $1.11 million | -$0.05 | -$0.05 | 0% |
| 2007-12-31 | 2008-03-26 | $1.98 million | -$0.05 | -$0.03 | -66.67% |
| 2007-09-30 | 2007-11-13 | $1.23 million | -$0.04 | -$0.04 | 0% |
| 2007-06-30 | 2007-08-13 | $1.81 million | -$0.04 | -$0.05 | 20% |
| 2007-03-31 | 2007-05-15 | $2.84 million | -$0.01 | -$0.01 | 0% |
| 2006-12-31 | 2007-03-27 | $2.02 million | -$0.03 | -$0.04 | 25% |
| 2006-09-30 | 2006-11-14 | $756000 | -$0.04 | -$0.04 | 0% |
| 2006-06-30 | 2006-08-14 | $859000 | -$0.05 | -$0.05 | 0% |
| 2006-03-31 | 2006-05-15 | $637000 | -$0.05 | -$0.05 | 0% |
| 2005-12-31 | 2006-03-21 | $734000 | -$0.05 | ||
| 2005-09-30 | 2005-11-14 | $444000 | -$0.05 | ||
| 2005-06-30 | 2005-08-15 | $493000 | -$0.06 | -$0.05 | -20% |
| 2005-03-31 | 2005-05-10 | $554000 | -$0.06 | ||
| 2004-12-31 | 2005-03-21 | $716000 | -$0.06 | ||
| 2004-09-30 | 2004-11-15 | $613000 | -$0.06 | ||
| 2004-06-30 | 2004-08-13 | $691000 | -$0.05 | ||
| 2004-03-31 | 2004-05-14 | $726000 | -$0.07 | ||
| 2003-12-31 | 2004-03-29 | $929000 | -$0.15 | ||
| 2003-09-30 | 2003-11-14 | $1.04 million | -$1.40 | ||
| 2003-06-30 | 2003-08-14 | $908000 | -$0.31 | ||
| 2003-03-31 | 2003-05-20 | $910000 | -$0.26 | ||
| 2002-12-31 | 2003-03-18 | $966000 | -$0.37 | -$0.20 | -85% |
| 2002-09-30 | 2002-11-06 | $1.23 million | -$0.21 | -$0.21 | 0% |
| 2002-06-30 | 2002-06-30 | $1.13 million | -$0.21 | ||
| 2002-03-31 | 2002-03-31 | $669000 | -$0.23 | ||
| 2001-12-31 | 2001-12-31 | $1.21 million | -$0.33 | ||
| 2001-09-30 | 2001-09-30 | $597000 | -$0.24 | ||
| 2001-06-30 | 2001-06-30 | $1.11 million | -$0.20 | ||
| 2001-03-31 | 2001-03-31 | $587000 | -$0.99 | ||
| 2000-12-31 | 2000-12-31 | $170000 | -$1.45 | ||
| 2000-09-30 | 2000-09-30 | $134000 | -$0.82 | ||
| 2000-06-30 | 2000-06-30 | $187000 | -$0.66 | ||
| 2000-03-31 | 2000-03-31 | $69000 | -$0.62 | ||
| 1999-09-30 | 1999-09-30 | -$0.84 | |||
| 1999-06-30 | 1999-06-30 | -$0.72 | |||
| 1999-03-31 | 1999-03-31 | -$0.20 | |||
| 1998-12-31 | 1999-02-25 | -$1.83 | -$0.50 | -266% | |
| 1998-09-30 | 1998-11-06 | -$0.90 | -$0.55 | -63.64% | |
| 1998-06-30 | 1998-07-31 | -$0.75 | -$0.65 | -15.38% | |
| 1998-03-31 | 1998-04-24 | -$0.60 | -$0.40 | -50% | |
| 1997-12-31 | 1998-02-20 | -$0.45 | -$0.45 | 0% | |
| 1997-09-30 | 1997-10-29 | -$0.65 | -$0.52 | -25% | |
| 1997-06-30 | 1997-07-29 | -$0.60 | -$0.40 | -50% | |
| 1997-03-31 | 1997-05-06 | -$0.40 | -$0.30 | -33.33% | |
| 1996-12-31 | 1997-02-24 | -$0.35 | -$0.40 | 12.5% |
Antares Pharma, Inc (ATRS) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Research Development | 2.32 million | 2.41 million | N/A | N/A | 2.88 million |
| Income Before Tax | 5.11 million | 5 million | N/A | -2.36 million | 4.7 million |
| Selling General Administrative | 16.66 million | 15.23 million | N/A | 16.42 million | 15.37 million |
| Gross Profit | 25.05 million | 23.49 million | N/A | 18.03 million | 23.81 million |
| Ebit | 6.08 million | 5.78 million | N/A | N/A | 5.57 million |
| Operating Income | 6.1 million | 5.85 million | N/A | -1.37 million | 5.57 million |
| Income Tax Expense | -46.28 million | N/A | N/A | N/A | N/A |
| Total Revenue | 44.11 million | 40 million | N/A | 33.08 million | 37.84 million |
| Cost of Revenue | 19.06 million | 16.52 million | N/A | 15.05 million | 14.03 million |
| Total Other Income Expense Net | N/A | N/A | N/A | N/A | -872000 |
| Net Income From Continuing Operations | 51.39 million | 5 million | N/A | N/A | 4.7 million |
| Net Income Applicable to Common Shares | 51.39 million | 5 million | 2.18 million | -2.36 million | 4.7 million |
Cash Flow:
| Date | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | 6 million | N/A | N/A | -22.65 million | N/A |
| Change to Liabilities | 5.21 million | -1.51 million | 5.79 million | -3.42 million | 5.03 million |
| Total Cash Flow from Investing Activities | 551000 | 6.7 million | 5.36 million | -21.22 million | -170000 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 1.11 million | N/A | N/A | 3.68 million | 176000 |
| Change to Operating Activities | N/A | 2.35 million | -1.21 million | 161000 | 3.76 million |
| Change in Cash | 6.61 million | N/A | N/A | -18.67 million | 1.7 million |
| Total Cash from Operating Activities | 4.96 million | 3.68 million | 5.58 million | -1.13 million | 1.7 million |
| Depreciation | 598000 | N/A | N/A | 641000 | 578000 |
| Other Cash Flow from Investing Activities | N/A | N/A | N/A | N/A | N/A |
| Change to Inventory | -204000 | N/A | N/A | 178000 | -1.27 million |
| Change to Account Receivables | N/A | N/A | N/A | -5.67 million | -9.22 million |
| Other Cash Flow from Financing Activities | -16000 | N/A | N/A | N/A | N/A |
| Change to Net Income | 1.95 million | 2.36 million | 2.12 million | 2.29 million | 1.77 million |
| Capital Expenditures | 5.45 million | N/A | N/A | 1.08 million | 170000 |
Balance Sheet:
| Date | Dec 31 2020 | Sep 30 2020 | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 93.42 million | 90.33 million | N/A | 83.01 million | 78.25 million |
| Total Stockholder Equity | 119.12 million | 65.24 million | N/A | 53.8 million | 54.5 million |
| Other Current Liabilities | 5.15 million | 3.28 million | N/A | N/A | 13.78 million |
| Total Assets | 212.53 million | 155.57 million | N/A | 136.8 million | 132.75 million |
| Common Stock | 1.67 million | 1.67 million | 57.33 million | N/A | 1.65 million |
| Other Current Assets | 13.02 million | 10.64 million | N/A | N/A | N/A |
| Retained Earnings | -222.63 million | -274.01 million | N/A | N/A | -278.83 million |
| Other Liabilities | N/A | N/A | N/A | N/A | N/A |
| Other Assets | N/A | N/A | 6.35 million | 4.88 million | 1.31 million |
| Cash | 53.14 million | 50.17 million | N/A | 50.32 million | 23.2 million |
| Total Current Liabilities | 63.21 million | 50.55 million | N/A | 37.26 million | 32.42 million |
| Other Stockholder Equity | -683000 | -691000 | N/A | 53.8 million | -702000 |
| Property, Plant & Equipment | 24.02 million | 22.55 million | 24.31 million | 16.22 million | 21.42 million |
| Total Current Assets | 126.59 million | 125.12 million | N/A | 108.97 million | 108.45 million |
| Long Term Investments | N/A | N/A | N/A | N/A | N/A |
| Net Tangible Assets | 110.33 million | 65.24 million | 57.33 million | N/A | 52.93 million |
| Short Term Investments | N/A | 2 million | N/A | N/A | 22.52 million |
| Long Term Debt | 24.67 million | 34.36 million | N/A | 45.75 million | 40.4 million |
| Inventory | 18.22 million | 19.81 million | N/A | 17.31 million | 16 million |
| Accounts Payable | 41.83 million | 40.86 million | N/A | N/A | 12.91 million |
Antares Pharma, Inc (ATRS) Chart:
Antares Pharma, Inc (ATRS) News:
Below you will find a list of latest news for Antares Pharma, Inc (ATRS) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Antares Pharma, Inc (ATRS) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Antares Pharma, Inc (ATRS) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020029559/0001564590-20-029559-index.htm |
| 2019-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000021545719003140/0000215457-19-003140-index.htm |
| 2020-02-05 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000083423720004581/0000834237-20-004581-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000091957419001695/0000919574-19-001695-index.htm |
| 2020-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000091957420001522/0000919574-20-001522-index.htm |
| 2019-07-23 | S-8 | Securities to be offered to employees in employee benefit plans | https://www.sec.gov/Archives/edgar/data/1016169/000110465919041470/0001104659-19-041470-index.htm |
| 2019-04-26 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1016169/000114036119007713/0001140361-19-007713-index.htm |
| 2019-04-29 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1016169/000114036119007745/0001140361-19-007745-index.htm |
| 2020-04-27 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/1016169/000114036120009845/0001140361-20-009845-index.htm |
| 2020-04-27 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material | https://www.sec.gov/Archives/edgar/data/1016169/000114036120009847/0001140361-20-009847-index.htm |
| 2018-11-15 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000119312518327214/0001193125-18-327214-index.htm |
| 2019-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000119312519041213/0001193125-19-041213-index.htm |
| 2019-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000119312519213487/0001193125-19-213487-index.htm |
| 2020-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/1016169/000119312520030594/0001193125-20-030594-index.htm |
| 2018-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035887/0001209191-18-035887-index.htm |
| 2018-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035890/0001209191-18-035890-index.htm |
| 2018-06-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035892/0001209191-18-035892-index.htm |
| 2018-06-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118036498/0001209191-18-036498-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037098/0001209191-18-037098-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037101/0001209191-18-037101-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037103/0001209191-18-037103-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037105/0001209191-18-037105-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037107/0001209191-18-037107-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037109/0001209191-18-037109-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037115/0001209191-18-037115-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037117/0001209191-18-037117-index.htm |
| 2018-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037119/0001209191-18-037119-index.htm |
| 2018-06-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037537/0001209191-18-037537-index.htm |
| 2018-06-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118038837/0001209191-18-038837-index.htm |
| 2018-08-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118045752/0001209191-18-045752-index.htm |
| 2018-08-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118045755/0001209191-18-045755-index.htm |
| 2018-08-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118046267/0001209191-18-046267-index.htm |
| 2018-08-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118046882/0001209191-18-046882-index.htm |
| 2018-08-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118048223/0001209191-18-048223-index.htm |
| 2018-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118054297/0001209191-18-054297-index.htm |
| 2018-12-14 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118062810/0001209191-18-062810-index.htm |
| 2018-12-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919118062812/0001209191-18-062812-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119012774/0001209191-19-012774-index.htm |
| 2019-02-22 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119012777/0001209191-19-012777-index.htm |
| 2019-02-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119014615/0001209191-19-014615-index.htm |
| 2019-03-05 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119016858/0001209191-19-016858-index.htm |
| 2019-03-05 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119016881/0001209191-19-016881-index.htm |
| 2019-04-10 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119024300/0001209191-19-024300-index.htm |
| 2019-05-03 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119027494/0001209191-19-027494-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119034411/0001209191-19-034411-index.htm |
| 2019-06-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119034416/0001209191-19-034416-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119036134/0001209191-19-036134-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119036139/0001209191-19-036139-index.htm |
| 2019-06-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119036147/0001209191-19-036147-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037209/0001209191-19-037209-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037211/0001209191-19-037211-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037213/0001209191-19-037213-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037223/0001209191-19-037223-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037232/0001209191-19-037232-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037237/0001209191-19-037237-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037242/0001209191-19-037242-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037248/0001209191-19-037248-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037250/0001209191-19-037250-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037255/0001209191-19-037255-index.htm |
| 2019-06-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037257/0001209191-19-037257-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119054796/0001209191-19-054796-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119054797/0001209191-19-054797-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119056440/0001209191-19-056440-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119056446/0001209191-19-056446-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2019-12-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060113/0001209191-19-060113-index.htm |
| 2019-12-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919119061964/0001209191-19-061964-index.htm |
| 2020-01-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2020-01-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120003358/0001209191-20-003358-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011709/0001209191-20-011709-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011718/0001209191-20-011718-index.htm |
| 2020-02-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011721/0001209191-20-011721-index.htm |
| 2020-05-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120029742/0001209191-20-029742-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120035377/0001209191-20-035377-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120035380/0001209191-20-035380-index.htm |
| 2020-06-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120035382/0001209191-20-035382-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036751/0001209191-20-036751-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036757/0001209191-20-036757-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036768/0001209191-20-036768-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036771/0001209191-20-036771-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036775/0001209191-20-036775-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036778/0001209191-20-036778-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036786/0001209191-20-036786-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036791/0001209191-20-036791-index.htm |
| 2020-06-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036849/0001209191-20-036849-index.htm |
| 2018-06-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018015029/0001564590-18-015029-index.htm |
| 2018-06-14 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018015628/0001564590-18-015628-index.htm |
| 2018-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018019642/0001564590-18-019642-index.htm |
| 2018-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459018019977/0001564590-18-019977-index.htm |
| 2018-09-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018022747/0001564590-18-022747-index.htm |
| 2018-10-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018023817/0001564590-18-023817-index.htm |
| 2018-11-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018027076/0001564590-18-027076-index.htm |
| 2018-11-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459018027476/0001564590-18-027476-index.htm |
| 2018-12-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459018030874/0001564590-18-030874-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019000268/0001564590-19-000268-index.htm |
| 2019-02-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019005167/0001564590-19-005167-index.htm |
| 2019-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019005951/0001564590-19-005951-index.htm |
| 2019-03-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019006161/0001564590-19-006161-index.htm |
| 2019-03-12 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1016169/000156459019007398/0001564590-19-007398-index.htm |
| 2019-05-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019015030/0001564590-19-015030-index.htm |
| 2019-05-02 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459019015362/0001564590-19-015362-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019022723/0001564590-19-022723-index.htm |
| 2019-06-18 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019022766/0001564590-19-022766-index.htm |
| 2019-06-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019023664/0001564590-19-023664-index.htm |
| 2019-07-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019024598/0001564590-19-024598-index.htm |
| 2019-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459019029313/0001564590-19-029313-index.htm |
| 2019-09-10 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019034467/0001564590-19-034467-index.htm |
| 2019-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459019040061/0001564590-19-040061-index.htm |
| 2019-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459019040388/0001564590-19-040388-index.htm |
| 2020-01-13 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020000924/0001564590-20-000924-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020001957/0001564590-20-001957-index.htm |
| 2020-03-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020008268/0001564590-20-008268-index.htm |
| 2020-03-03 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/1016169/000156459020008465/0001564590-20-008465-index.htm |
| 2020-03-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020008657/0001564590-20-008657-index.htm |
| 2020-04-09 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020016107/0001564590-20-016107-index.htm |
| 2020-05-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020020996/0001564590-20-020996-index.htm |
| 2020-05-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459020021313/0001564590-20-021313-index.htm |
| 2020-06-16 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020029559/0001564590-20-029559-index.htm |
| 2020-08-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020037250/0001564590-20-037250-index.htm |
| 2020-08-06 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459020037823/0001564590-20-037823-index.htm |
| 2020-09-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020044128/0001564590-20-044128-index.htm |
| 2020-10-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020045404/0001564590-20-045404-index.htm |
| 2020-11-05 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/1016169/000156459020050873/0001564590-20-050873-index.htm |
| 2020-11-05 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/1016169/000156459020051289/0001564590-20-051289-index.htm |
Antares Pharma, Inc (ATRS) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Antares Pharma, Inc (ATRS). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 749%Institutional Ownership: 4395%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2018-08-08 | JACQUES GONELLA | Director | Sell | 250,493.00 | 3.09 | 774,023.37 | 10,035,355.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118046267/0001209191-18-046267-index.htm |
| 2020-01-02 | MARVIN SAMSON | Director | Buy | 49,395.00 | 2.18 | 107,681.10 | 101,146.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2020-01-02 | MARVIN SAMSON | Director | Buy | 50,000.00 | 2.18 | 109,000.00 | 101,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2018-06-15 | JACQUES GONELLA | Director | Sell | 565.00 | 2.95 | 1,666.75 | 10,285,848.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118038837/0001209191-18-038837-index.htm |
| 2018-06-12 | JACQUES GONELLA | Director | Sell | 100,000.00 | 2.77 | 277,000.00 | 10,286,413.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037537/0001209191-18-037537-index.htm |
| 2018-06-11 | JACQUES GONELLA | Director | Sell | 100,000.00 | 2.69 | 269,000.00 | 10,386,413.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037537/0001209191-18-037537-index.htm |
| 2018-06-06 | JACQUES GONELLA | Director | Sell | 20,259.00 | 2.70 | 54,699.30 | 10,486,413.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118036498/0001209191-18-036498-index.htm |
| 2018-06-05 | JACQUES GONELLA | Director | Sell | 23,129.00 | 2.70 | 62,448.30 | 10,506,672.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118036498/0001209191-18-036498-index.htm |
| 2018-06-05 | JACQUES GONELLA | Director | Sell | 100,000.00 | 2.55 | 255,000.00 | 10,529,801.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035892/0001209191-18-035892-index.htm |
| 2018-06-04 | JACQUES GONELLA | Director | Sell | 100,000.00 | 2.65 | 265,000.00 | 10,629,801.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035892/0001209191-18-035892-index.htm |
| 2018-06-01 | JACQUES GONELLA | Director | Sell | 56,612.00 | 2.70 | 152,852.40 | 10,729,801.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118035892/0001209191-18-035892-index.htm |
| 2019-06-13 | ROBERT P JR ROCHE | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 112,145.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037248/0001209191-19-037248-index.htm |
| 2020-06-11 | ROBERT P JR ROCHE | Director | Buy | 30,220.00 | 2.73 | 82,500.60 | 142,365.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036757/0001209191-20-036757-index.htm |
| 2018-06-08 | ROBERT F APPLE | President & CEO | Buy | 305,556.00 | 2.70 | 825,001.20 | 1,530,562.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037098/0001209191-18-037098-index.htm |
| 2018-08-21 | ROBERT F APPLE | President & CEO | Sell | 43,000.00 | 3.75 | 161,250.00 | 1,530,562.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118048223/0001209191-18-048223-index.htm |
| 2018-08-21 | ROBERT F APPLE | President & CEO | Buy | 43,000.00 | 0.47 | 20,210.00 | 1,573,562.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118048223/0001209191-18-048223-index.htm |
| 2019-05-01 | THOMAS J GARRITY | Director | Sell | 30,000.00 | 2.67 | 79,968.00 | 160,213.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119027494/0001209191-19-027494-index.htm |
| 2019-02-20 | ROBERT F APPLE | President & CEO | Buy | 254,205.00 | 1,784,767.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119012774/0001209191-19-012774-index.htm | ||
| 2019-06-13 | THOMAS J GARRITY | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 184,186.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037237/0001209191-19-037237-index.htm |
| 2019-06-13 | ROBERT F APPLE | President & CEO | Buy | 282,534.00 | 2.92 | 824,999.28 | 1,849,336.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037209/0001209191-19-037209-index.htm |
| 2019-05-01 | THOMAS J GARRITY | Director | Buy | 30,000.00 | 0.53 | 15,900.00 | 190,213.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119027494/0001209191-19-027494-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Sell | 110,000.00 | 4.58 | 503,426.00 | 1,905,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Sell | 97,000.00 | 4.62 | 448,411.60 | 1,905,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Sell | 100,000.00 | 4.68 | 467,830.00 | 1,905,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Sell | 1,000.00 | 4.75 | 4,750.00 | 1,905,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-10 | ROBERT F APPLE | President & CEO | Sell | 58,524.00 | 4.76 | 278,357.70 | 1,905,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Buy | 1,000.00 | 3.96 | 3,960.00 | 1,906,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-11-01 | THOMAS J GARRITY | Director | Buy | 10,000.00 | 1.10 | 11,000.00 | 194,186.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119054797/0001209191-19-054797-index.htm |
| 2019-12-09 | THOMAS J GARRITY | Director | Sell | 40,000.00 | 4.58 | 183,236.00 | 194,186.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060113/0001209191-19-060113-index.htm |
| 2019-11-11 | ROBERT F APPLE | President & CEO | Buy | 100,000.00 | 1.10 | 110,000.00 | 1,949,336.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119056440/0001209191-19-056440-index.htm |
| 2019-12-10 | ROBERT F APPLE | President & CEO | Buy | 58,524.00 | 3.96 | 231,755.04 | 1,964,415.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Buy | 97,000.00 | 1.66 | 161,020.00 | 2,002,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Buy | 100,000.00 | 1.52 | 152,000.00 | 2,005,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-09 | ROBERT F APPLE | President & CEO | Buy | 110,000.00 | 2.94 | 323,400.00 | 2,015,891.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060108/0001209191-19-060108-index.htm |
| 2019-12-23 | MARVIN SAMSON | Director | Buy | 150,000.00 | 1.12 | 168,000.00 | 201,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119061964/0001209191-19-061964-index.htm |
| 2020-02-19 | ROBERT F APPLE | President & CEO | Buy | 210,782.00 | 2,116,673.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011709/0001209191-20-011709-index.htm | ||
| 2019-12-09 | LEONARD S JACOB | Director | Sell | 84,814.00 | 4.63 | 392,833.00 | 212,749.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2020-06-11 | THOMAS J GARRITY | Director | Buy | 30,220.00 | 2.73 | 82,500.60 | 224,406.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036751/0001209191-20-036751-index.htm |
| 2020-06-11 | ROBERT F APPLE | President & CEO | Buy | 402,930.00 | 2.73 | 1,099,998.90 | 2,336,047.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036786/0001209191-20-036786-index.htm |
| 2019-12-09 | THOMAS J GARRITY | Director | Buy | 40,000.00 | 1.60 | 64,000.00 | 234,186.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060113/0001209191-19-060113-index.htm |
| 2019-12-09 | THOMAS J GARRITY | Director | Buy | 40,000.00 | 1.66 | 66,400.00 | 234,186.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060113/0001209191-19-060113-index.htm |
| 2019-06-13 | Karen L. Smith | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 23,973.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037257/0001209191-19-037257-index.htm |
| 2019-06-13 | Peter Greenleaf | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 23,973.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037255/0001209191-19-037255-index.htm |
| 2019-04-08 | LEONARD S JACOB | Director | Sell | 92,078.00 | 3.00 | 276,243.21 | 239,892.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119024300/0001209191-19-024300-index.htm |
| 2020-06-11 | LEONARD S JACOB | Director | Buy | 40,293.00 | 2.73 | 109,999.89 | 253,042.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036775/0001209191-20-036775-index.htm |
| 2019-06-13 | LEONARD S JACOB | Director | Buy | 37,671.00 | 2.92 | 109,999.32 | 277,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037232/0001209191-19-037232-index.htm |
| 2018-06-08 | PETER J GRAHAM | EVP General Counsel, Secretary | Buy | 91,667.00 | 2.70 | 247,500.90 | 289,173.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037103/0001209191-18-037103-index.htm |
| 2019-10-31 | LEONARD S JACOB | Director | Buy | 20,000.00 | 1.10 | 22,000.00 | 297,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119054796/0001209191-19-054796-index.htm |
| 2019-12-09 | LEONARD S JACOB | Director | Sell | 80,000.00 | 4.62 | 369,776.00 | 297,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2019-12-09 | LEONARD S JACOB | Director | Sell | 80,000.00 | 4.63 | 370,536.00 | 297,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2019-04-08 | LEONARD S JACOB | Director | Buy | 62,078.00 | 0.53 | 32,901.34 | 301,970.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119024300/0001209191-19-024300-index.htm |
| 2019-06-13 | ANTON GUETH | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 326,749.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037242/0001209191-19-037242-index.htm |
| 2019-04-08 | LEONARD S JACOB | Director | Buy | 30,000.00 | 0.53 | 15,900.00 | 331,970.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119024300/0001209191-19-024300-index.htm |
| 2019-02-20 | PETER J GRAHAM | EVP General Counsel, Secretary | Buy | 84,735.00 | 373,908.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119012777/0001209191-19-012777-index.htm | ||
| 2019-12-09 | LEONARD S JACOB | Director | Buy | 80,000.00 | 1.60 | 128,000.00 | 377,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2019-12-09 | LEONARD S JACOB | Director | Buy | 80,000.00 | 1.66 | 132,800.00 | 377,563.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119060111/0001209191-19-060111-index.htm |
| 2019-06-13 | PETER J GRAHAM | EVP General Counsel, Secretary | Buy | 84,760.00 | 2.92 | 247,499.20 | 386,261.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037213/0001209191-19-037213-index.htm |
| 2020-05-13 | ANTON GUETH | Director | Buy | 72,487.00 | 1.60 | 115,979.20 | 399,236.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120029742/0001209191-20-029742-index.htm |
| 2018-06-08 | Fred M Powell | Executive Vice President & CFO | Buy | 91,667.00 | 2.70 | 247,500.90 | 413,492.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118037101/0001209191-18-037101-index.htm |
| 2020-06-11 | ANTON GUETH | Director | Buy | 30,220.00 | 2.73 | 82,500.60 | 429,456.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036768/0001209191-20-036768-index.htm |
| 2020-02-19 | PETER J GRAHAM | EVP General Counsel, Secretary | Buy | 63,234.00 | 449,495.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011721/0001209191-20-011721-index.htm | ||
| 2019-06-13 | James Patrick Tursi | EVP, Chief Medical Officer | Buy | 45,205.00 | 2.92 | 131,998.60 | 45,205.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037223/0001209191-19-037223-index.htm |
| 2019-06-13 | Fred M Powell | Executive Vice President & CFO | Buy | 90,411.00 | 2.92 | 264,000.12 | 485,610.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037211/0001209191-19-037211-index.htm |
| 2020-06-11 | PETER J GRAHAM | EVP General Counsel, Secretary | Buy | 131,868.00 | 2.73 | 359,999.64 | 517,161.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036778/0001209191-20-036778-index.htm |
| 2019-12-23 | MARVIN SAMSON | Director | Sell | 150,000.00 | 4.71 | 706,500.00 | 51,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119061964/0001209191-19-061964-index.htm |
| 2020-01-02 | MARVIN SAMSON | Director | Sell | 50,000.00 | 4.59 | 229,500.00 | 51,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2020-01-02 | MARVIN SAMSON | Director | Sell | 49,395.00 | 4.60 | 227,217.00 | 51,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2020-01-10 | MARVIN SAMSON | Director | Sell | 56.00 | 4.50 | 252.00 | 51,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120003358/0001209191-20-003358-index.htm |
| 2020-01-10 | MARVIN SAMSON | Director | Buy | 56.00 | 2.66 | 148.96 | 51,807.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120003358/0001209191-20-003358-index.htm |
| 2020-01-02 | MARVIN SAMSON | Director | Buy | 549.00 | 2.66 | 1,460.34 | 52,300.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120002077/0001209191-20-002077-index.htm |
| 2020-06-11 | Karen L. Smith | Director | Buy | 30,220.00 | 2.73 | 82,500.60 | 54,193.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036849/0001209191-20-036849-index.htm |
| 2020-06-11 | Peter Greenleaf | Director | Buy | 30,220.00 | 2.73 | 82,500.60 | 54,193.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036771/0001209191-20-036771-index.htm |
| 2020-02-19 | Fred M Powell | Executive Vice President & CFO | Buy | 63,234.00 | 548,844.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120011718/0001209191-20-011718-index.htm | ||
| 2020-06-11 | Fred M Powell | Executive Vice President & CFO | Buy | 131,868.00 | 2.73 | 359,999.64 | 638,629.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919120036791/0001209191-20-036791-index.htm |
| 2019-06-13 | MARVIN SAMSON | Director | Buy | 23,973.00 | 2.92 | 70,001.16 | 76,751.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119037250/0001209191-19-037250-index.htm |
| 2019-02-26 | JACQUES GONELLA | Director | Sell | 200,000.00 | 3.65 | 730,000.00 | 9,385,848.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919119014615/0001209191-19-014615-index.htm |
| 2018-10-02 | JACQUES GONELLA | Director | Sell | 400,000.00 | 3.79 | 1,516,000.00 | 9,585,848.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118054297/0001209191-18-054297-index.htm |
| 2018-08-13 | JACQUES GONELLA | Director | Sell | 49,507.00 | 3.09 | 152,976.63 | 9,985,848.00 | https://www.sec.gov/Archives/edgar/data/1016169/000120919118046882/0001209191-18-046882-index.htm |